Claris Limited is a leading drug and formulation manufacturer committed to producing high-quality medications, improving global health, and advancing medical innovation. With a diverse range of businesses, Claris has positioned itself for new growth and opportunities through investments and management interest in clean energy, venture capital, and incubators. Founded in 1999, Claris Lifesciences specialized in niche and high-entry barrier businesses, becoming one of the largest sterile generic injectables companies in India.

With approvals from stringent regulatory bodies like the US FDA, MHRA (UK), and TGA (Australia), Claris established itself as a trusted provider of pharmaceutical products. In recent years, Claris has transitioned from healthcare and sold its injectables and infusions businesses to focus on new ventures. Led by Vice Chairman and MD Arjun Handa, known for his visionary leadership, Claris has leveraged cutting-edge manufacturing capabilities and a people-centric culture to achieve accelerated growth.

Arjun's commitment to innovation and creating a positive work environment has earned Claris numerous awards, including India's Best Companies To Work For award for eight consecutive years. Beyond business, Claris is dedicated to social causes, supporting sports and fitness, fostering entrepreneurship, and promoting art and culture. Claris Limited is dedicated to transforming possibilities into realities, driven by innovation and a desire to make a sustainable impact